propantheline has been researched along with Compensatory Hyperinsulinemia in 1 studies
Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davidson, MB | 1 |
| Forsythe, AB | 1 |
1 other study available for propantheline and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Dietary and anticholinergic effects on intravenous glucose tolerance and insulin secretion.
Topics: Administration, Oral; Adult; Body Weight; Diet; Dietary Carbohydrates; Energy Intake; Fasting; Gluco | 1978 |